VEGFA and preeclampsia: That study included 230 pregnant women, and its primary outcome was obtained upon analysis of the concentration of the receptor-1 of the vascular endothelial growth factor soluble in serum (sF1t-1), an antiangiogenic factor linked to the preeclampsia risk.